Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

RecruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
MigraineEpisodic MigraineChronic Migraine, Headache
Interventions
DRUG

CGRP antibody or gepant

Patients will start anti-CGRP or its receptor antibody or gepants

Trial Locations (26)

33136

RECRUITING

University of Miami, Miller School of Medicine, Miami

Unknown

RECRUITING

FLENI, Buenos Aires

RECRUITING

Pontificia Universidad Católica de Chile, Santiago

RECRUITING

Neuromedica, Medellín

RECRUITING

"Special Hospital for Orthopedics and Rehabilitation Martin Horvat Rovinj-Rovigno", Rovinj

RECRUITING

Charité Universitätsmedizin Berlin, Berlin

RECRUITING

LMU University Hospital, München

RECRUITING

University of L'Aquila, L’Aquila

RECRUITING

University of Modena and Reggio Emilia, Modena

RECRUITING

National Neurological Institute C. Mondino Foundation, Pavia

RECRUITING

IRCCS San Raffaele, Roma

RECRUITING

Universiti Putra Malaysia, Serdang

RECRUITING

Neuroclinic Norway, Lillestrøm

RECRUITING

Wrocław Medical University, Wroclaw

RECRUITING

Hospital Santa Maria Lisbon, Lisbon

RECRUITING

Germans Trias i Pujol Hospital, Badalona

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

NOT_YET_RECRUITING

Fundació Sanitària Mollet, Mollet del Vallès

RECRUITING

Hospital de Viladecans, Viladecans

RECRUITING

Hospital General Universitario de Albacete, Albacete

RECRUITING

Fundación Jiménez Díaz, Madrid

RECRUITING

Hospital Universitario Gregorio Marañón, Madrid

RECRUITING

La Paz University Hospital, Madrid

RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza

RECRUITING

Mersin University, Mersin

08035

RECRUITING

Vall d'Hebron University Hospital, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER